Skip to main content

and
  1. No Access

    Article

    The prevalence of mild cognitive impairment in breast cancer patients receiving chemotherapy according to the criteria of the National Institute on Aging-Alzheimer’s Association (NIA-AA)

    Breast cancer patients receiving chemotherapy can develop cognitive impairment. There is no gold standard for defining cognitive impairment. We applied the National Institute on Aging-Alzheimer’s Association (...

    E. A. C. Albers, J. M. Kieffer, S. B. Schagen in Journal of Cancer Survivorship (2024)

  2. No Access

    Article

    Inter-observer variation of hippocampus delineation in hippocampal avoidance prophylactic cranial irradiation

    Hippocampal avoidance prophylactic cranial irradiation (HA-PCI) techniques have been developed to reduce radiation damage to the hippocampus. An inter-observer hippocampus delineation analysis was performed an...

    F. Bartel, M. van Herk, H. Vrenken, F. Vandaele in Clinical and Translational Oncology (2019)

  3. No Access

    Article

    Quantification of patient-reported outcome measures of radiation-induced skin reactions for use in clinical trial design

    Skin toxicity is a common effect from radiotherapy, although difficult to predict on an individual basis, and there is little evidence-based management. This study aimed to quantify inter-patient variation in ...

    N. S. Russell, E. van Werkhoven, S. B. Schagen in Supportive Care in Cancer (2017)